AK-1 has been reported to stabilize microtubes, improve cell survival, alleviate the toxicity of Aβ oligomers (Silva et al., 2017), and increase the level of acetylated α-tubulin as well as decrease tau phosphorylation (Esteves et al., 2019) in AD. The gene discussed is MAPT; the disease is Alzheimer disease.